We are live on ! Find out more
Boston Trust Walden

Boston Trust Walden Portfolio holdings

AUM $13.1B Turnover 6.42%
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH icon
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 16.24%
3 Technology 15.4%
4 Industrials 13.98%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
APAM icon
151
Artisan Partners
APAM
$2.29B
$13.3M 0.2%
337,515
-10,945
-3% -$406K
2013 Q2
18 quarters
SBNY
152
DELISTED
Signature Bank
SBNY
$13.2M 0.19%
96,259
+972
+1% +$128K
2013 Q2
18 quarters
FET icon
153
Forum Energy Technologies
FET
$903M
$13.2M 0.19%
42,318
-1,820
-4% -$518K
2013 Q2
18 quarters
JLL icon
154
Jones Lang LaSalle
JLL
$14.1B
$13.1M 0.19%
88,117
-4,770
-5% -$674K
2013 Q2
18 quarters
AVY icon
155
Avery Dennison
AVY
$13.3B
$12.9M 0.19%
112,401
-3,320
-3% -$359K
2015 Q3
9 quarters
LKFN icon
156
Lakeland Financial Corp
LKFN
$1.44B
$12.7M 0.19%
262,922
-6,943
-3% -$340K
2015 Q2
10 quarters
DEO icon
157
Diageo
DEO
$52.9B
$12.7M 0.19%
86,741
-210
-0.2% -$28.9K
2013 Q2
18 quarters
TNC icon
158
Tennant Co
TNC
$1.11B
$12.6M 0.18%
173,425
-89,485
-34% -$5.97M
2013 Q3
17 quarters
SAM icon
159
Boston Beer
SAM
$1.86B
$12.5M 0.18%
65,497
-764
-1% -$136K
2016 Q1
7 quarters
TMP icon
160
Tompkins Financial
TMP
$1.4B
$12.3M 0.18%
151,436
-4,306
-3% -$366K
2014 Q2
14 quarters
DOX icon
161
Amdocs
DOX
$6.27B
$12.2M 0.18%
186,381
+3,067
+2% +$199K
2016 Q1
7 quarters
AFG icon
162
American Financial Group
AFG
$12.4B
$12M 0.18%
110,163
+2,111
+2% +$222K
2016 Q2
6 quarters
SEIC icon
163
SEI Investments
SEIC
$12.5B
$11.9M 0.17%
165,948
+1,774
+1% +$119K
2013 Q2
18 quarters
RVTY icon
164
Revvity
RVTY
$17B
$11.5M 0.17%
157,250
+23,071
+17% +$1.66M
2017 Q2
2 quarters
KWR icon
165
Quaker Houghton
KWR
$2.7B
$11.5M 0.17%
76,097
-1,718
-2% -$266K
2013 Q2
18 quarters
RPM icon
166
RPM International
RPM
$12.7B
$11.4M 0.17%
217,456
+14,182
+7% +$742K
2017 Q2
2 quarters
SAFM
167
DELISTED
Sanderson Farms Inc
SAFM
$11.3M 0.17%
81,692
-33,717
-29% -$5.21M
2015 Q4
8 quarters
INDB icon
168
Independent Bank
INDB
$3.78B
$11.1M 0.16%
159,451
-78,241
-33% -$5.6M
2013 Q2
18 quarters
WAB icon
169
Wabtec
WAB
$48.4B
$11.1M 0.16%
136,096
+3,205
+2% +$245K
2013 Q2
18 quarters
LAMR icon
170
Lamar Advertising Co
LAMR
$15.2B
$11M 0.16%
148,784
-1,408
-0.9% -$103K
2016 Q2
6 quarters
COO icon
171
Cooper Companies
COO
$11B
$10.9M 0.16%
200,944
+8,060
+4% +$471K
2014 Q1
15 quarters
APA icon
172
APA Corp
APA
$17.2B
$10.9M 0.16%
259,039
-6,865
-3% -$289K
2013 Q2
18 quarters
SLB icon
173
SLB Ltd
SLB
$73.5B
$10.8M 0.16%
160,969
-1,970
-1% -$128K
2013 Q2
18 quarters
ANSS icon
174
DELISTED
Ansys
ANSS
$10.8M 0.16%
73,447
+986
+1% +$140K
2017 Q2
2 quarters
ILG
175
DELISTED
ILG, Inc Common Stock
ILG
$10.8M 0.16%
380,572
-287,777
-43% -$8.3M
2014 Q3
13 quarters
5 6
7
8 9

Similar funds

Markel Group
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Great Lakes Advisors
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
Van Lanschot Kempen Investment Management
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
Brinker Capital Investments
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EdgePoint Investment Group
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
Penserra Capital Management
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Westwood Holdings Group
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.